The oncogenic activation of PI3K-AKT-mTOR signaling can activate sterol regulatory element-binding protein 1 (SREBP1), a central transcription factor that regulates lipid metabolism, which then affects adipogenesis in HCC, thereby killing cancer cells. This evidence concerns the gene SREBF1 and hepatocellular carcinoma.